2009
DOI: 10.1111/j.1526-4610.2009.01493.x
|View full text |Cite
|
Sign up to set email alerts
|

Occipital Nerve Blocks: When and What to Inject?

Abstract: Occipital nerve block is an effective treatment for cervicogenic headache, cluster headache, and occipital neuralgia. While a double blinded randomized placebo controlled clinical trial is lacking, multiple open label studies reported favorable results for migraine. Two other possible uses of ONB worthy of further study are use as a rescue treatment and as an adjunctive treatment for medication overuse headache. ONB may be effective for tension headache, but only under very specific circumstances. ONB is eithe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
47
0
3

Year Published

2010
2010
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(55 citation statements)
references
References 39 publications
0
47
0
3
Order By: Relevance
“…The scope of our study was to analyse the clinical outcome during the first week, concluding that GON block significantly reduces the number of moderate-to-severe headaches (and total number of headaches), at least in the short term. GON tenderness to palpation did not predict a favourable response, even though this clinical finding has been used by some practitioners as a selection criterion for the performance of GON blocks (40); this is in line with an open-label study that could not find an association between the degree of tenderness and treatment outcome in patients with CM (36). Otherwise, we were not able to find any effect of GON blocks on acute medication consumption; however, this could be explained by the exclusion of patients with medication overuse, or the low response rate of chronic pain to symptomatic treatments.…”
Section: Discussionmentioning
confidence: 92%
“…The scope of our study was to analyse the clinical outcome during the first week, concluding that GON block significantly reduces the number of moderate-to-severe headaches (and total number of headaches), at least in the short term. GON tenderness to palpation did not predict a favourable response, even though this clinical finding has been used by some practitioners as a selection criterion for the performance of GON blocks (40); this is in line with an open-label study that could not find an association between the degree of tenderness and treatment outcome in patients with CM (36). Otherwise, we were not able to find any effect of GON blocks on acute medication consumption; however, this could be explained by the exclusion of patients with medication overuse, or the low response rate of chronic pain to symptomatic treatments.…”
Section: Discussionmentioning
confidence: 92%
“…As for CeH, the cervical C1-C2 and C2-C3 facet joint blocks, as well as C2 and C3 spinal rami (including the lesser and third occipital nerves) blocks induced prolonged pain relief in more than 90% of the patients [80]. The greater occipital nerve can be easily blocked and serves as important diagnostic evidence if a temporary relief is obtained [81,82]. A greater occipital nerve block study in CeH showed significant improvement after 2 weeks [83].…”
Section: Treatmentmentioning
confidence: 96%
“…PTHAs with neuralgiform pain such as occipital or trigeminal neuralgia may benefit from treatment with an anticonvulsant such as carbamazepine, gabapentin, or lamotrigine. Occipital nerve blocks, consisting of injection of an anesthetic agent with or without corticosteroids, are used to treat a wide variety of headache syndromes [52]. A small case series of 10 patients with PTHA reported an 80% response rate with occipital nerve blockade [53,Class IV].…”
Section: Pharmacologic Treatmentmentioning
confidence: 99%